Dexcel Pharma Technologies Ltd., 10% Owner at Roivant Sciences Ltd. (ROIV), bought 71,970 shares at $3.83 ($276K) on 2022-04-22, disclosed to the SEC on 2022-04-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.83 | 31,685 | $121K | 43.9% |
| 2 | $3.83 | 31,685 | $121K | 43.9% |
| 3 | $3.91 | 8,600 | $34K | 12.2% |
| Total | $3.84 avg | 71,970 | $276K | 100% |
| Filing → |
| UROV | BUY | 2019-06-14 | $355K | — | Filing → |
| UROV | BUY | 2019-06-11 | $292K | — | Filing → |
| MYOV | BUY | 2019-06-06 | $40.0M | — | Filing → |